Barclays raised the firm’s price target on Emerson (EMR) to $112 from $104 and keeps an Underweight rating on the shares. The firm sees a narrowing in end market growth dispersion, which could also yield a narrowing in the dispersion of estimate revision momentum, and hence valuation multiples, across the multi-industry sector.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson price target raised to $135 from $121 at Wells Fargo
- Emerson Electric: Poised for Growth with Innovative Solutions and Margin Expansion Potential
- Emerson price target raised to $150 from $135 at Mizuho
- Emerson price target raised to $133 from $113 at JPMorgan
- Emerson price target raised to $133 from $127 at Citi